Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: Evaluation of an Apoptotic Test for Predicting Late Toxicities After Radiotherapy in Breast and Prostate Cancer Patients
A completed trial evaluated an apoptotic biomarker test to predict late toxicities after radiotherapy in breast and prostate cancer patients…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Image-Guidance and Online Adaptation With Stereotactic Body Radiation Therapy for the Treatment of Localized Prostate Cancer, MANTICORE Trial [NA]
Clinical trial update for the MANTICORE trial evaluating image-guided, online adaptive stereotactic body radiotherapy for localized prostate…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Prostate Adaptive Radiation Therapy [NA]
Clinical trial update indicates a prostate adaptive radiation therapy study is currently recruiting at Royal North Shore Hospital.
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: ArtemiCoffee in Patients With Rising PSA [Phase 2]
A Phase 2 clinical trial update for ArtemiCoffee in prostate cancer patients with rising PSA, currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Clinico-biological Database in Patients Treated With Metabolic Radiotherapy in the Nuclear Medicine Department [NA]
Clinical trial update describing a clinico-biological database for patients treated with metabolic radiotherapy in the Nuclear Medicine depa…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Hypofractionated WPPT With HDR Boost [Phase 2]
Phase 2 clinical trial update on hypofractionated WPPT with HDR boost for prostate cancer; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation Therapy [Phase 3]
A Phase 3 clinical trial is evaluating whether adding rucaparib to enzalutamide improves outcomes for men with metastatic castration-resista…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Fezolinetant for Treating Hot Flashes in Men With Prostate Cancer [Phase 2]
A Phase 2 trial is evaluating fezolinetant for hot flashes in men with prostate cancer receiving androgen deprivation therapy, and the study…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Effect of Education to be Provided to Patients to Undergo TURP With Mobile Application on Patient Outcomes [NA]
This clinical trial update describes a study evaluating whether an education program delivered via a mobile app to patients undergoing TURP …
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Hypofractionated Radiotherapy With a Focal Microboost for High-Risk and Locally Advanced Prostate Cancer [Phase 2]
Phase 2 trial update describes hypofractionated radiotherapy with a focal microboost for high-risk and locally advanced prostate cancer. The…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Daily Adaptive Radiation Therapy Using an Individualized Approach for Prostate Cancer [NA]
Clinical trial update indicates daily adaptive radiation therapy using an individualized approach for prostate cancer is currently in the re…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Pharmaceutical Management in Targeted Radioligand Therapy
Clinical trial update indicates a study on pharmaceutical management in targeted radioligand therapy is currently recruiting at Hospices Civ…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: PSMA-Targeted Intraoperative Fluorescent Imaging Agents (DGPR1008): Validation Across Different Time Windows [Phase 2]
Phase 2 trial update on validating DGPR1008, a PSMA-targeted intraoperative fluorescent imaging agent, across different time windows in pros…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial [Phase 2]
Phase 2 trial (IMPACT-ADT) evaluating time-restricted eating, a GLP-1 receptor agonist, and a heart-healthy diet to improve cardiometabolic …
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Mainstreaming Genetics: Evaluation of a Digital Application to Scale and Spread Oncologist-initiated Genetic Testing [NA]
This clinical trial update describes evaluating a digital application designed to scale oncologist-initiated genetic testing across multiple…
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: Impact on Quality of Life and Health of the CONTINUUM+ CONNECT Remote Monitoring Solution [NA]
Completed clinical trial update evaluating the CONTINUUM+ CONNECT remote monitoring solution and its impact on quality of life and health ou…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
This update describes the Moonshot Study's genetic analysis of blood and tissue samples from patients with advanced cancer; the study status…
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer [Phase 1]
Phase 1 safety and dose-finding study of PRL-02 Depot in men with advanced prostate cancer is currently recruiting, indicating early clinica…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: The BARCODE 2 Study - The Use of Genetic Profiling to Guide Prostate Cancer Treatment [Phase 2]
The BARCODE 2 trial is a Phase 2 study using genetic profiling to guide treatment for hormone-refractory prostate cancer; the trial is curre…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: WALNUTS for POWER: Polyphenols, Omega-3 Fatty Acids, Weight Loss, and EneRgy [Phase 2]
Phase 2 clinical trial update for WALNUTS for POWER evaluating walnuts as a dietary intervention in men with prostate cancer; study currentl…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: The Role of 18F-PSMA PET in Prostate Cancer Diagnosis in Equivocal MRI [NA]
This clinical trial update from the Chinese University of Hong Kong describes a study evaluating 18F-PSMA PET imaging for diagnosing prostat…
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: Sarcopenia in Older Patient With Prostate Cancer, Prevalence and Incidence After Androgen Deprivation Therapy
This completed clinical trial update reports the prevalence and incidence of sarcopenia in older patients with prostate cancer after androge…
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: Exploring Men s Prostate Cancer Genetic Risk Perceptions
A completed clinical trial at H. Lee Moffitt Cancer Center studied men's perceptions of genetic risk related to prostate cancer.
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Micro-Ultrasound for Detecting Clinically Significant Prostate Cancer in Active Surveillance [NA]
This clinical trial is evaluating micro-ultrasound for detecting clinically significant prostate cancer in men under active surveillance; th…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: A Pilot Study of Dose dE-eScalaTion IN prostATe radIOtherapy usiNg the MRL [NA]
Pilot dose-escalation study in prostate radiotherapy using the MRL, sponsored by The Netherlands Cancer Institute; the trial is active but n…